Annual Operating Expenses
$106.82 M
-$3.90 M-3.52%
December 1, 2024
Summary
- As of March 12, 2025, TBPH annual total operating expenses is $106.82 million, with the most recent change of -$3.90 million (-3.52%) on December 1, 2024.
- During the last 3 years, TBPH annual operating expenses has fallen by -$186.14 million (-63.54%).
- TBPH annual operating expenses is now -71.09% below its all-time high of $369.48 million, reached on December 31, 2020.
Performance
TBPH Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$27.95 M
+$1.81 M+6.93%
December 1, 2024
Summary
- As of March 12, 2025, TBPH quarterly total operating expenses is $27.95 million, with the most recent change of +$1.81 million (+6.93%) on December 1, 2024.
- Over the past year, TBPH quarterly operating expenses has stayed the same.
- TBPH quarterly operating expenses is now -72.07% below its all-time high of $100.07 million, reached on December 31, 2019.
Performance
TBPH Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
TBPH Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.5% | 0.0% |
| 3 y3 years | -63.5% | 0.0% |
| 5 y5 years | -67.2% | -70.6% |
TBPH Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -63.5% | at low | -47.0% | +17.4% |
| 5 y | 5-year | -71.1% | at low | -72.1% | +17.4% |
| alltime | all time | -71.1% | at low | -72.1% | +17.4% |
Theravance Biopharma Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $106.82 M(-3.5%) | $27.95 M(+6.9%) |
| Sep 2024 | - | $26.14 M(-3.2%) |
| Jun 2024 | - | $27.01 M(+5.1%) |
| Mar 2024 | - | $25.71 M(+8.0%) |
| Dec 2023 | $110.72 M(-15.1%) | $23.80 M(-2.6%) |
| Sep 2023 | - | $24.45 M(-14.8%) |
| Jun 2023 | - | $28.70 M(-15.0%) |
| Mar 2023 | - | $33.76 M(+5.2%) |
| Dec 2022 | $130.47 M(-55.5%) | $32.08 M(+22.7%) |
| Sep 2022 | - | $26.14 M(-16.1%) |
| Jun 2022 | - | $31.15 M(-24.2%) |
| Mar 2022 | - | $41.09 M(-22.1%) |
| Dec 2021 | $292.95 M(-20.7%) | $52.74 M(-18.9%) |
| Sep 2021 | - | $65.04 M(-15.6%) |
| Jun 2021 | - | $77.02 M(-21.5%) |
| Mar 2021 | - | $98.15 M(+3.2%) |
| Dec 2020 | $369.48 M(+13.6%) | $95.09 M(+0.2%) |
| Sep 2020 | - | $94.87 M(+8.8%) |
| Jun 2020 | - | $87.18 M(-5.6%) |
| Mar 2020 | - | $92.34 M(-7.7%) |
| Dec 2019 | $325.33 M(+9.0%) | $100.07 M(+28.9%) |
| Sep 2019 | - | $77.63 M(+13.1%) |
| Jun 2019 | - | $68.63 M(-13.1%) |
| Mar 2019 | - | $79.00 M(+1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $298.41 M(+10.7%) | $77.73 M(+4.2%) |
| Sep 2018 | - | $74.58 M(+1.3%) |
| Jun 2018 | - | $73.63 M(+1.6%) |
| Mar 2018 | - | $72.47 M(-10.1%) |
| Dec 2017 | $269.48 M(+19.1%) | $80.58 M(+33.7%) |
| Sep 2017 | - | $60.29 M(-10.4%) |
| Jun 2017 | - | $67.27 M(+9.6%) |
| Mar 2017 | - | $61.35 M(-1.6%) |
| Dec 2016 | $226.22 M(+3.1%) | $62.38 M(+19.4%) |
| Sep 2016 | - | $52.24 M(-0.2%) |
| Jun 2016 | - | $52.33 M(-11.7%) |
| Mar 2016 | - | $59.27 M(+5.0%) |
| Dec 2015 | $219.37 M(-8.7%) | $56.47 M(+6.1%) |
| Sep 2015 | - | $53.21 M(+2.5%) |
| Jun 2015 | - | $51.92 M(-10.1%) |
| Mar 2015 | - | $57.77 M(-9.7%) |
| Dec 2014 | $240.17 M(+53.5%) | $63.96 M(+14.2%) |
| Sep 2014 | - | $56.03 M(-5.7%) |
| Jun 2014 | - | $59.40 M(-2.3%) |
| Mar 2014 | - | $60.77 M(+37.3%) |
| Dec 2013 | $156.51 M(+12.0%) | $44.26 M(+7.7%) |
| Sep 2013 | - | $41.10 M(+5.5%) |
| Jun 2013 | - | $38.96 M(+21.0%) |
| Mar 2013 | - | $32.20 M |
| Dec 2012 | $139.72 M | - |
FAQ
- What is Theravance Biopharma annual total operating expenses?
- What is the all time high annual operating expenses for Theravance Biopharma?
- What is Theravance Biopharma annual operating expenses year-on-year change?
- What is Theravance Biopharma quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Theravance Biopharma?
- What is Theravance Biopharma quarterly operating expenses year-on-year change?
What is Theravance Biopharma annual total operating expenses?
The current annual operating expenses of TBPH is $106.82 M
What is the all time high annual operating expenses for Theravance Biopharma?
Theravance Biopharma all-time high annual total operating expenses is $369.48 M
What is Theravance Biopharma annual operating expenses year-on-year change?
Over the past year, TBPH annual total operating expenses has changed by -$3.90 M (-3.52%)
What is Theravance Biopharma quarterly total operating expenses?
The current quarterly operating expenses of TBPH is $27.95 M
What is the all time high quarterly operating expenses for Theravance Biopharma?
Theravance Biopharma all-time high quarterly total operating expenses is $100.07 M
What is Theravance Biopharma quarterly operating expenses year-on-year change?
Over the past year, TBPH quarterly total operating expenses has changed by $0.00 (0.00%)